Institutional Ownership Avidity Biosciences, Inc. (RNA)

RNA Quotes by TradingView

This table provides information about the institutional ownership of Avidity Biosciences, Inc. (RNA). We have compiled data on the 260 institutions that hold shares in the stock, with a total of 100 Million shares, which have been reported (via 13F filing form) to have a value of $2.95 Billion.

Holding Report Date shares Held Holding Value (Reported) Last Trade Trade History
Price T Rowe Associates Inc

Baltimore, MD

 		Feb 14, 2025 Q4 2024
11,042,823
shares
$325 Million 0.04% of portfolio
Q4 2024 Added 3.84%
Vanguard Group Inc

Valley Forge, PA

 		Feb 11, 2025 Q4 2024
9,431,911
shares
$278 Million 0.0% of portfolio
Q4 2024 Added 2.22%
Black Rock Inc.

New York, NY

 		Aug 13, 2024 Q2 2024
8,622,513
shares
$254 Million 0.01% of portfolio
Q2 2024 Added 39.84%
Rtw Investments, LP

New York, NY

 		Feb 14, 2025 Q4 2024
7,932,870
shares
$234 Million 3.76% of portfolio
Q4 2024 Reduced 2.46%
Avoro Capital Advisors LLC

New York, NY

 		Feb 14, 2025 Q4 2024
7,500,000
shares
$221 Million 3.18% of portfolio
Q4 2024 Added 9.09%
Janus Henderson Group PLC

London, X0

 		Feb 14, 2025 Q4 2024
7,053,010
shares
$208 Million 0.11% of portfolio
Q4 2024 Added 44.05%
Ra Capital Management, L.P.

Boston, MA

 		Feb 14, 2025 Q4 2024
6,300,408
shares
$186 Million 2.97% of portfolio
Q3 2024 Added 16.67%
State Street Corp

Boston, MA

 		Feb 14, 2025 Q4 2024
4,602,191
shares
$136 Million 0.01% of portfolio
Q4 2024 Reduced 2.21%
Geode Capital Management, LLC

Boston, MA

 		Feb 12, 2025 Q4 2024
2,807,455
shares
$82.7 Million 0.01% of portfolio
Q4 2024 Added 8.59%
Adage Capital Partners Gp, L.L.C.

Boston, MA

 		Feb 14, 2025 Q4 2024
2,751,944
shares
$81 Million 0.15% of portfolio
Q4 2024 Reduced 10.63%
Polar Capital Holdings PLC

London, X0

 		Feb 14, 2025 Q4 2024
1,271,891
shares
$37.5 Million 0.23% of portfolio
Q4 2024 Reduced 17.52%
Driehaus Capital Management LLC

Chicago, IL

 		Feb 14, 2025 Q4 2024
1,228,058
shares
$36.2 Million 0.35% of portfolio
Q4 2024 Added 40.84%
Morgan Stanley

New York, NY

 		Feb 14, 2025 Q4 2024
1,213,776
shares
$35.7 Million 0.0% of portfolio
Q4 2024 Added 98.58%
Siren, L.L.C.

New York, NY

 		Feb 14, 2025 Q4 2024
1,127,295
shares
$33.2 Million 1.45% of portfolio
Q4 2024 Reduced 21.76%
Orbimed Advisors LLC

San Diego, CA

 		Feb 14, 2025 Q4 2024
1,112,886
shares
$32.8 Million 0.88% of portfolio
Q4 2024 Added 6.52%
Northern Trust Corp

Chicago, IL

 		Feb 14, 2025 Q4 2024
1,079,434
shares
$31.8 Million 0.0% of portfolio
Q4 2024 Added 11.15%
Cormorant Asset Management, LP

Boston, MA

 		Feb 14, 2025 Q4 2024
1,050,000
shares
$30.9 Million 2.41% of portfolio
Q3 2024 Added 147.06%
Charles Schwab Investment Management Inc

San Francisco, CA

 		Feb 06, 2025 Q4 2024
1,028,931
shares
$30.3 Million 0.01% of portfolio
Q4 2024 Added 3.91%
Artisan Partners Limited Partnership

Milwaukee, WI

 		Feb 12, 2025 Q4 2024
1,015,251
shares
$29.9 Million 0.05% of portfolio
Q4 2024 Reduced 23.62%
Woodline Partners LP

San Francisco, CA

 		Feb 14, 2025 Q4 2024
865,820
shares
$25.5 Million 0.19% of portfolio
Q4 2024 Added 27.67%
Pictet Asset Management Holding Sa

Carouge, V8

 		Feb 12, 2025 Q4 2024
799,028
shares
$23.5 Million 0.03% of portfolio
Q4 2024 Added 1.6%
Goldman Sachs Group Inc

New York, NY

 		Feb 11, 2025 Q4 2024
763,055
shares
$22.5 Million 0.0% of portfolio
Q4 2024 Reduced 12.77%
Norges Bank

Oslo, Q8

 		Feb 12, 2025 Q4 2024
724,787
shares
$21.3 Million 0.0% of portfolio
Q4 2024 New holding
Bio Impact Capital LLC

Cambridge, MA

 		Feb 14, 2025 Q4 2024
702,981
shares
$20.7 Million 3.06% of portfolio
Q4 2024 Added 2.03%

Track Institutional and Insider Activities on RNA

Follow Avidity Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if
Any

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Avidity Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RNA